Used in cancer research to target integrin β1 (ITGB1), this reference antibody supports studies on tumor cell adhesion, migration, and survival. It is applied in functional assays to block integrin-mediated signaling, helping evaluate the role of ITGB1 in tumor progression and metastasis. Commonly used in flow cytometry, immunoprecipitation, and in vivo models to investigate immune cell interactions and stromal engagement. Supports development of therapeutic antibodies by serving as a benchmark for binding specificity and biological activity. Also utilized in studies of fibrosis and inflammation due to integrin’s role in cell-matrix interactions.